Zidovudine and Lamivudine tablets

Zidoramidivudine tablets are indicated for HIV-infected adults and children over 12 years old who have progressive immune deficiency (CD4 count ≤ (smaller than or equal to) 500 cells/mm3). This product can reduce the viral load of HIV-1 and increase the number of CD4+ cells. Clinical results show that combined treatment with lamivudine alone and zidovudine, or a combination of zidovudine and other drugs, can significantly reduce the risk of disease progression and mortality.